Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green i fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Chaorattanakawee, Suwanna ^a   Tyner, Stuart D ^a   Lon, Chanthap ^a   Yingyuen, Kritsanai ^a   Ruttvisutinunt, Wiriya ^a   Sundrakes, Siratchana ^a   Sai Gnam, Piyaporn ^a   Johnson, Jacob D ^b   Walsh, Douglas S ^a   Saunders, David L ^a   Lanteri, Charlotte A ^a  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Cambodia; HRP 2 ELISA; Immediate ex vivo Plasmodium falciparum drug susceptibility testing; Malaria SYBR green fluorescence assay

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; DIHYDROARTEMISININ; HISTIDINE RICH PROTEIN 2; MEFLOQUINE; MEMBRANE PROTEIN; PIPERAQUINE; QUININE SULFATE; UNCLASSIFIED DRUG;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CAMBODIA; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE TRANSMISSION; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLUORESCENCE ANALYSIS; HISTIDINE RICH PROTEIN 2 ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IC 50; LEUKOCYTE; LIMIT OF DETECTION; MALARIA; MALARIA SYBR GREEN I FLUORESCENCE; MULTIDRUG RESISTANCE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CAMBODIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; ORGANIC CHEMICALS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROTEINS; PROTOZOAN PROTEINS; STAINING AND LABELING; YOUNG ADULT;

EID: 84880014965     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-239     Document Type: Article

References (35)

1. Visual in-vitro test for determining the drug sensitivity of Plasmodium falciparum. Rieckmann KH, Lancet 1982 1 1333 1335 (Pubitemid 12119221)
2. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 (Pubitemid 10082023)
3. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS, AmJTrop Med Hyg 2004 71 711 714 (Pubitemid 40075618)
4. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Noedl H, Wernsdorfer WH, Miller RS, Wongsrichanalai C, Antimicrob Agents Chemother 2002 46 1658 1664 (Pubitemid 34535179)
5. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC, Antimicrob Agents Chemother 2007 51 1926 1933 (Pubitemid 46903075)
6. Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isol ates determined by a SYBR green I in vitro assay and molecular analysis. Akala HM, Eyase FL, Cheruiyot AC, Omondi AA, Ogutu BR, Waters NC, Johnson JD, Polhemus ME, Schnabel DC, Walsh DS, AmJTrop Med Hyg 2011 85 34 41
7. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M, Antimicrob Agents Chemother 2004 48 1803 1806 (Pubitemid 38544392)
8. The SYBR gr een I malaria drug sensitivity assay: performance in low parasitemia samples. Vossen MG, Pferschy S, Chiba P, Noedl H, AmJTrop Med Hyg 2010 82 398 401
9. Ex vivo drug sensitivity profiles of plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidinerich protein-2 assay. Tyner SD, Lon C, Se Y, Bethell D, Socheat D, Noedl H, Sea D, Satimai W, Schaecher K, Rutvisuttinunt W, Fukuda MM, Chaorattanakawee S, Yingyuen K, Sundrakes S, Chaichana P, Saingam P, Buathong N, Sriwichai S, Chann S, Timmermans A, Saunders DL, Walsh DS, Malar J 2012 11 198
10. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, Darapiseth S, Teja-Isavadharm P, Khemawoot P, Schaecher K, Ruttvisutinunt W, Lin J, Kuntawungin W, Gosi P, Timmermans A, Smith B, Socheat D, Fukuda MM, PLoS One 2011 6 19283
11. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M, Antimicrob Agents Chemother 2005 49 3575 3577 (Pubitemid 41060624)
12. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Socheat D, Lon C, Clin Infect Dis 2010 51 82 e89
13. Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Le Bras J, Deloron P, Ricour A, Andrieu B, Savel J, Coulaud JP, Exp Parasitol 1983 56 9 14 (Pubitemid 13002717)
14. Complexity of Plasmodium falciparum clinical samples from uganda during short-term culture. Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ, J Infect Dis 2008 198 1554 1557
15. Differential association of Plasmodium falciparum Na+/H + exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum. Pelleau S, Bertaux L, Briolant S, Ferdig MT, Sinou V, Pradines B, Parzy D, Jambou R, Antimicrob Agents Chemother 2011 55 5834 5841
16. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S, Antimicrob Agents Chemother 2007 51 1172 1178 (Pubitemid 46586790)
17. Performance and reliability of the SYBR green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D, Trans R Soc Trop Med Hyg 2008 102 346 351
18. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675
19. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003. Chaijaroenkul W, Bangchang KN, Mungthin M, Ward SA, Malar J 2005 4 37
20. Synchronization of Plasmodium falciparum erythrocytic stages in culture. Lambros C, Vanderberg JP, J Parasitol 1979 65 418 420 (Pubitemid 10222999)
21. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates. Rutvisuttinunt W, Chaorattanakawee S, Tyner SD, Teja-Isavadharm P, Se Y, Yingyuen K, Chaichana P, Bethell D, Walsh DS, Lon C, Fukuda M, Socheat D, Noedl H, Schaecher K, Saunders DL, Malar J 2012 11 325
22. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Le Nagard H, Vincent C, Mentre F, Le Bras J, Comput Methods Programs Biomed 2011 104 10 18
23. Comparing methods of measurement: why plotting difference against standard method is misleading. Bland JM, Altman DG, Lancet 1995 346 1085 1087
24. Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Parasitology 1999 119 Pt 5 435 440
25. Molecular epidemiology of malaria in Cameroon. XX. experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. Basco LK, AmJTrop Med Hyg 2004 70 474 480 (Pubitemid 38658140)
26. Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H, J Clin Microbiol 2010 48 1651 1660
27. Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures. Smeijsters LJ, Zijlstra NM, Franssen FF, Overdulve JP, Antimicrob Agents Chemother 1996 40 835 838 (Pubitemid 26115213)
28. Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Desakorn V, Silamut K, Angus B, Sahassananda D, Chotivanich K, Suntharasamai P, Simpson J, White NJ, Trans R Soc Trop Med Hyg 1997 91 479 483 (Pubitemid 27421249)
29. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620
30. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. O'Brien C, Henrich PP, Passi N, Fidock DA, Curr Opin Infect Dis 2011 24 570 577
31. Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. implications for mechanism of action of and resistance to the drug. Geary TG, Divo AD, Jensen JB, Zangwill M, Ginsburg H, Biochem Pharmacol 1990 40 685 691 (Pubitemid 20246571)
32. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Hawley SR, Bray PG, Mungthin M, Atkinson JD, O'Neill PM, Ward SA, Antimicrob Agents Chemother 1998 42 682 686 (Pubitemid 28114827)
33. Access to hematin: the basis of chloroquine resistance. Bray PG, Mungthin M, Ridley RG, Ward SA, Mol Pharmacol 1998 54 170 179 (Pubitemid 28337600)
34. Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia plasmodium infected erythrocytes. Moneriz C, Marin-Garcia P, Bautista JM, Diez A, Puyet A, Malar J 2009 8 279
35. P. falciparum drug sensitivity assay using SYBR® Green I Assay Technique WWARN Procedure, In vitro Module WWARN 2011